Myriad Genetics Inc.
13.37
-0.31 (-2.27%)
At close: Jan 15, 2025, 10:03 AM

Myriad Genetics Inc. Revenue Breakdown

Quarter Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015
Diagnostics Revenue 161.70M 177.10M 157.80M 130.50M 150.50M 177.60M 170.40M 200.50M 203.00M 189.00M 179.70M 179.20M 178.80M 187.90M 185.20M 183.90M 165.10M 173.70M 177.40M 182.60M 171.90M
Diagnostics Revenue Growth -8.70% +12.23% +20.92% -13.29% -15.26% +4.23% -15.01% -1.23% +7.41% +5.18% +0.28% +0.22% -4.84% +1.46% +0.71% +11.39% -4.95% -2.09% -2.85% +6.22% n/a
Other Segments Revenue 5.60M 12.30M 15.30M 14.70M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 12.60M 12.40M 12.70M 13.10M 10.70M 11.60M
Other Segments Revenue Growth -54.47% -19.61% +4.08% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a +1.61% -2.36% -3.05% +22.43% -7.76% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021
Non-Us Revenue 81.50M 44.10M 40.50M
Non-Us Revenue Growth +84.81% +8.89% n/a
United States Revenue 671.70M 84.50M 24.20M
United States Revenue Growth +694.91% +249.17% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 139.10M 144.90M 140.60M 32.60M 170.40M 218.20M 151.70M 146.50M 130.50M 127.10M 110.60M 141.50M 180.20M 134.80M 145.50M 132.90M 124.10M 107.40M 132.90M 135.60M 135.50M 149.80M 140.60M 135.20M 129.90M 121.40M 115.10M 115.40M 115.20M 122.10M 122.10M 120.30M 111.90M 91.30M 90.50M 90.80M 86.50M 97.50M 91.28M
Selling, General, and Administrative Revenue Growth -4.00% +3.06% +331.29% -80.87% -21.91% +43.84% +3.55% +12.26% +2.68% +14.92% -21.84% -21.48% +33.68% -7.35% +9.48% +7.09% +15.55% -19.19% -1.99% +0.07% -9.55% +6.54% +3.99% +4.08% +7.00% +5.47% -0.26% +0.17% -5.65% n/a +1.50% +7.51% +22.56% +0.88% -0.33% +4.97% -11.28% +6.82% n/a
Research and Development Revenue 28.50M 27.10M 24.90M 21.00M 24.00M 21.20M 22.50M 23.40M 20.50M 20.30M 21.20M 16.60M 18.80M 19.50M 23.10M 18.20M 17.60M 17.40M 19.70M 18.80M 21.30M 20.90M 21.50M 22.40M 21.10M 17.70M 18.50M 16.80M 17.80M 18.80M 17.60M 18.60M 19.40M 19.50M 17.20M 16.70M 17.20M 18.70M 16.67M
Research and Development Revenue Growth +5.17% +8.84% +18.57% -12.50% +13.21% -5.78% -3.85% +14.15% +0.99% -4.25% +27.71% -11.70% -3.59% -15.58% +26.92% +3.41% +1.15% -11.68% +4.79% -11.74% +1.91% -2.79% -4.02% +6.16% +19.21% -4.32% +10.12% -5.62% -5.32% +6.82% -5.38% -4.12% -0.51% +13.37% +2.99% -2.91% -8.02% +12.16% n/a